English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
you are here:
Success
Alert
Please select a Day.
Info

Dr Lal PathLabs Ltd.

Sector : Healthcare | Industry : Hospital & Healthcare Services
Add to

62/100
3,249.60
-69.80 (-2.10%)

As on 05 Sep, 2025 | 03:51

Open Trading A/c
Day Range
3229.40
3335.00
L H
52 Week Range
2293.55
3653.95
L H
Volume
362,259
*
i

* BSE Market Depth (05 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
1 3247.00 3257.85 1
7 3246.60 3260.95 7
7 3243.35 3264.55 7
5 3242.00 3268.05 11
3 3241.00 3280.00 80
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
62/100
3,255.80
-69.95 (-2.10%)

As on 05 Sep, 2025 | 04:01

Open Trading A/c
Day Range
3228.90
3336.70
L H
52 Week Range
2295.10
3645.00
L H
Volume
4,899
*
i

* BSE Market Depth (05 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
1 3247.00 3257.85 1
7 3246.60 3260.95 7
7 3243.35 3264.55 7
5 3242.00 3268.05 11
3 3241.00 3280.00 80
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
NSE
MC Essentials
65% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, High Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 3,309.00
          Previous Close 3,319.40
          Volume 362,259.00
          Value (Lacs) 11,771.97
            VWAP 3,253.46
          Beta
          Mkt Cap (Rs. Cr.) 27,224
          High 3,335.00
          Low 3,229.40
          UC Limit 3,983.20
          LC Limit 2,655.60
          52 Week High 3,653.95
          52 Week Low 2,293.55
          Face Value 10.00
          All Time High 4,245.50
          All Time Low 696.50
          20D Avg Volume 128,427
          20D Avg Delivery(%) 53.08
          Book Value Per Share 238.95
          Dividend Yield 0.74
          TTM EPS See historical trend 61.25 (+34.06% YoY)
          TTM PE See historical trend 53.05 (Low PE)
          P/B See historical trend 13.60 (Average P/B)
          Sector PE 49.25

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          62/100
          Average Financial Strength, High Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 11.07% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoters decreased holding from 53.91% to 53.79% in Jun 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          7 out of 10 years Dr Lal PathLabs has given negative returns in September.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          September 16.01% (2023) 11.28% -9.25% (2021) -3.91% 0.65%
          Seasonality Analysis

          News

          Dr. Lal PathLabs to Hold Analyst/Institutional Investor Meetings in September 2025

          Dr. Lal PathLabs to Hold Analyst/Institutional Investor Meetings in September 2025

          Aug 26 2025 12:02 PM

          ₹ Earning + See More

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Dr Lal PathLab

          What's your call on Dr Lal PathLab today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          20 Jul, 2025

          Emkay Global Financial Services

          Reco Price 3000.75 Target Price 3100
          26 Apr, 2025

          ICICI Securities

          Reco Price 2906.55 Target Price 2900
          26 Apr, 2025

          Emkay Global Financial Services

          Reco Price 2906.55 Target Price 3100
          30 Jan, 2025

          Emkay Global Financial Services

          Reco Price 2879.40 Target Price 3250
          24 Oct, 2024

          ICICI Securities

          Reco Price 3053.50 Target Price 3100
          08 Aug, 2024

          ICICI Securities

          Reco Price 3194.75 Target Price 3240
          Show More
          REFINITIV Report

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          06 Jan, 2025

          Multi-manager Icvc

          Qty 434943 Price 2997.11 % Traded 0.52

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Dr Lal PathLab 3,249.60 -2.10 27,223.69 53.05 13.60 22.42 -4.55 492 2,461 0.00
          Max Healthcare 1,170.00 0.84 113,750.54 99.15 12.93 11.46 32.13 1,075 7,028 0.27
          Apollo Hospital 7,804.50 -1.21 112,216.74 71.32 14.96 17.60 12.55 1,472 21,794 0.64
          Fortis Health 947.85 -0.21 71,558.71 82.42 9.12 8.68 68.91 797 7,782 0.25
          Global Health 1,408.40 -0.87 37,856.44 84.28 12.42 13.19 23.21 461 3,204 0.04
          + See More

          About the Company

          Dr. Lal Pathlabs Private Limited is recognized as a centre of innovation and a premier clinical pathology laboratory. It is the largest and most respected diagnostic service provider in the country.
          {"success":1,"data":{"address":{"address1":"Block E,\n","address2":"Sector 18, \n,Rohini,","city":"New Delhi","state":"Delhi","pincode":"110085","telephone1":"011-49885050","telephone2":"","fax1":"011-27882134","fax2":"","email":"cs@lalpathlabs.com","web":"https:\/\/www.lalpathlabs.com"},"management":[{"name":"Arvind Lal","designation":"Executive Chairman"},{"name":"Vandana Lal","designation":"Whole Time Director"},{"name":"Archana Lal Erdmann","designation":"Non Executive Director"},{"name":"Rahul Sharma","designation":"Non Executive Director"},{"name":"Arun Duggal","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"Noble Heights, Ist Floor, \nPlot NH 2, C-1 Block LS","address2":"","address3":"","address4":"","telephone":"011-49411000","fax":"011-41410591","email":"delhi@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"New Delhi","state":"Delhi","pincode":"110058"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"539524","nseId":"LALPATHLAB","series":"EQ","isinid":"INE600L01024"}}}

          • Registered Office

          • Registrars

          • Management

            • Arvind Lal

              Executive Chairman

            • Vandana Lal

              Whole Time Director

            • Archana Lal Erdmann

              Non Executive Director

            • Rahul Sharma

              Non Executive Director

            • Arun Duggal

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              No

          • Details

            • BSE:

              539524

            • NSE:

              LALPATHLAB

            • Series

              EQ

            • ISIN

              INE600L01024

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347